Clinical effects of statins: focusing on simvastatin
The role of statins in the treatment and secondary prevention of cardiovascular events and adverse outcomes among high-risk coronary heart disease patients is discussed, using well-known clinical trials on simvastatin as an example. Lipid-lowering and pleiotropic statin effects are analysed in detai...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2009-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1756 |
_version_ | 1797882674816221184 |
---|---|
author | D. M. Aronov M. G. Bubnova |
author_facet | D. M. Aronov M. G. Bubnova |
author_sort | D. M. Aronov |
collection | DOAJ |
description | The role of statins in the treatment and secondary prevention of cardiovascular events and adverse outcomes among high-risk coronary heart disease patients is discussed, using well-known clinical trials on simvastatin as an example. Lipid-lowering and pleiotropic statin effects are analysed in detail, by age, gender, and clinical group. |
first_indexed | 2024-04-10T03:39:34Z |
format | Article |
id | doaj.art-7d65adcf3438449fbd60120736e28dbe |
institution | Directory Open Access Journal |
issn | 1728-8800 2619-0125 |
language | Russian |
last_indexed | 2024-04-10T03:39:34Z |
publishDate | 2009-04-01 |
publisher | «SILICEA-POLIGRAF» LLC |
record_format | Article |
series | Кардиоваскулярная терапия и профилактика |
spelling | doaj.art-7d65adcf3438449fbd60120736e28dbe2023-03-13T07:23:16Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252009-04-018275811473Clinical effects of statins: focusing on simvastatinD. M. Aronov0M. G. Bubnova1Государственный научно-исследовательский центр профилактической медицины РосмедтехнологииГосударственный научно-исследовательский центр профилактической медицины РосмедтехнологииThe role of statins in the treatment and secondary prevention of cardiovascular events and adverse outcomes among high-risk coronary heart disease patients is discussed, using well-known clinical trials on simvastatin as an example. Lipid-lowering and pleiotropic statin effects are analysed in detail, by age, gender, and clinical group.https://cardiovascular.elpub.ru/jour/article/view/1756статинысимвастатинострый коронарный синдромишемическая болезнь сердцавторичная профилактика |
spellingShingle | D. M. Aronov M. G. Bubnova Clinical effects of statins: focusing on simvastatin Кардиоваскулярная терапия и профилактика статины симвастатин острый коронарный синдром ишемическая болезнь сердца вторичная профилактика |
title | Clinical effects of statins: focusing on simvastatin |
title_full | Clinical effects of statins: focusing on simvastatin |
title_fullStr | Clinical effects of statins: focusing on simvastatin |
title_full_unstemmed | Clinical effects of statins: focusing on simvastatin |
title_short | Clinical effects of statins: focusing on simvastatin |
title_sort | clinical effects of statins focusing on simvastatin |
topic | статины симвастатин острый коронарный синдром ишемическая болезнь сердца вторичная профилактика |
url | https://cardiovascular.elpub.ru/jour/article/view/1756 |
work_keys_str_mv | AT dmaronov clinicaleffectsofstatinsfocusingonsimvastatin AT mgbubnova clinicaleffectsofstatinsfocusingonsimvastatin |